We sought to validate these findings with tumour–immune cell interactions and spatial topologies from in situ mpIF profiling of principal immune cell types (T cells and macrophages) and their functional markers (PD-1, TOX, PD-L1) (Extended Data Fig. 13a). Here, PDCD1 is linked to neoplasm.